Publications

• Richard M. Goldberg, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Chapel Hill, NC Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA. Click here to read the full article.

 

• Midgley RS, McConkey C, Kerr DJ et al. Final Results of the VICTOR Trial: A Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer. Finalized and published J Clin Oncol 2010. Click here to read the full article.

 

• Kerr DJ, Midgley R. Can We Treat Cancer for a Dollar a Day?  Guidelines for Low-Income Countries. Accepted for publication N Engl J Med 2010

 

• Kerr DJ, Midgley R. Defective Mismatch Repair in Colon Cancer: A prognostic or predictive biomarker? Accepted for Publication  J Clin Oncol 2010

• Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. (2009); Genetic prognostic and predictive markers in colorectal cancer. Nature Rev Cancer 2009 Jul; 9(7):489-99. Click <here> to read the full article.

• Kerr DJ, Dunn JA, Langman MJ, Smith JL, Midgley RS, Stanley A, Stokes JC, Julier P, Iveson C, Duvvuri R, McConkey CC; VICTOR Trial Group.(2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 2007 July 7; 26;357(4):360-9. Click <here> to read the full article.

• Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ.(2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007 Dec 15; 370(9604):2020-9. Click <here> to read the full article.

• Midgley RS, Kerr DJ (2000) Towards post-genomic investigation of colorectal cancer  Lancet 2000 Feb 26; 355 : 669-670. Click <here> to read the full article.

• Kerr DJ, Gray R, McConkey C, Barnwell J. QUASAR Colorectal Cancer Study Group. (2000) Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain.  Ann Oncol. 2000 Aug; 11(8):947-55. Click <here> to read the full article.

• QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 2000 May 6; 355(9215):1588-96. Click <here> to read the full article.

 

• A. Weaver, A.M Young, J. Rowntree, N. Townsend, S. Pearson, J. Smith, O. Gibbon, W. Cobern, M. Larsen & L. Tarassenko (2007). Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007 Oct; 18: 1887-1892. Click <here> to read the full article.

• Mark E. Larsen, Joanna Rowntree, Annie M. Young, Sarah Pearson, Justine Smith, Oliver J. Gibson, Andrew Weaver, Lionel Tarassenko (2000) Chemotherapy Side-Effect Management Using Mobile Phones. 30^th Annual International IEEE EMBS Conference, Vancouver, BC, Canada, August 20-24, 2008. Follow link to read abstract: http://www.ncbi.nlm.nih.gov/pubmed/19163877